Objective Disease Progression DENDREON CORPORATION / L DENDREON CORPORATION / Cox / Survival (Months) DENDREON CORPORATION / Hepatitis B & C DENDREON CORPORATION / Hazard Ratio (95% Confidence Interval) DENDREON CORPORATION / DENDREON CORPORATION / WBC / /
Event
FDA Phase / /
MedicalCondition
resistant prostate cancer / HIV / No. Bone Metastases / Disease / Minimally Minimally Symptomatic Symptomatic Metastatic Metastatic Androgen Androgen Independent Independent Prostate Prostate Cancer Cancer / Hepatitis B / bone metastases / /